Disc Medicine, Inc. (IRON)
68.85
+0.53
(+0.78%)
USD |
NASDAQ |
Apr 24, 16:00
68.83
-0.02
(-0.03%)
After-Hours: 20:00
Disc Medicine Shareholders Equity (Quarterly) : 739.83M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amylyx Pharmaceuticals, Inc. | 305.26M |
| Eli Lilly & Co. | 26.54B |
| Masimo Corp. | 721.20M |
| Cytokinetics, Inc. | -659.62M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 806.88M |
| Total Liabilities (Quarterly) | 67.05M |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 21.94 |
| Net Debt Paydown Yield | -0.19% |